A growing epidemic that can affect up to 500,000 women every year, cervical cancer continues to be a health concern. Although there are with antioxidants that may help prevent cervical cancer, physicians are still looking for additional options for women.
According to new findings published in the journal Clinical Cancer Research, a new chemotherapy treatment known as Triapine may help reduce advanced cervical cancer in some women, in addition to controlling the disease from spreading.
Researchers found a success rate in the way the new treatment handled the disease, leading scientists to believe this could open doors for a potential cure.
“This new drug, which suppresses tumor growth, shows a great deal of promise for cervical cancer patients who are at high risk for relapse and cancer-related death,” said Dr. Charles Kunos, the studys lead researcher. “In this ten-patient study, a 100% complete response rate was observed and no disease progression was documented through 18 months of median follow-up.”
The scientists felt that this treatment discovery was “promising” and believed it could lead to a higher survival rate of the cancer.